Terms: = Bone cancer AND AXIN1, LA16c-314G4_3, 8312, ENSG00000103126, O15169, AXIN, MGC52315 AND Treatment
23071 results:
1. Second Chance for Cure: Stereotactic Ablative Radiotherapy in Oligometastatic Disease.
Salim N; Tumanova K; Popodko A; Libson E
JCO Glob Oncol; 2024 May; 10():e2300275. PubMed ID: 38754052
[TBL] [Abstract] [Full Text] [Related]
2. Cell Cycle Checkpoints p16 and p21-Strong Predictors of Clinicopathologic Outcomes in High-Grade Osteosarcoma.
Nasri E; Torrence DE; Vasilopoulos T; Knapik JA; Lagmay JP; Reith JD; Gibbs CP
Cancer J; 2024 May-Jun 01; 30(3):133-139. PubMed ID: 38753746
[TBL] [Abstract] [Full Text] [Related]
3. Construction of a prognostic model for extensive-stage small cell lung cancer patients undergoing immune therapy in northernmost China and prediction of treatment efficacy based on response status at different time points.
Dang J; Xu G; Guo G; Zhang H; Shang L
J Cancer Res Clin Oncol; 2024 May; 150(5):255. PubMed ID: 38750370
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic nomogram in middle-aged and elderly patients with chordoma: A SEER-based study.
Ouyang C; Sun Y; Li Y; Jiang M; Nong L; Gao G
J Orthop Surg (Hong Kong); 2024; 32(2):10225536241254208. PubMed ID: 38744697
[TBL] [Abstract] [Full Text] [Related]
5. [Clinical characteristics and prognosis analysis of gastric cancer patients with bone metastasis].
Zhang MM; Lai M; Li YT; An Y; Yuan WZ
Zhonghua Zhong Liu Za Zhi; 2024 May; 46(5):438-448. PubMed ID: 38742357
[No Abstract] [Full Text] [Related]
6. [Aprospective study of detection and clinical significance of bone marrow tumor cells in small cell lung cancer].
Wang Y; Lu BH; Gao Y; Liu YX; Hu MM; Che NY; Lin HF; Li HX; Zhang HM; Zhang TM
Zhonghua Zhong Liu Za Zhi; 2024 May; 46(5):419-427. PubMed ID: 38742355
[No Abstract] [Full Text] [Related]
7. Real-world data on diagnostics, treatment and outcomes of patients with hairy cell leukemia: The HCL-CLLEAR study.
Panovská A; Žák P; Jurková T; Arpáš T; Brychtová Y; Vašíková A; Hrabčáková V; Prchlíková A; Filipová M; Doubek M
Hematol Oncol; 2024 May; 42(3):e3280. PubMed ID: 38741354
[TBL] [Abstract] [Full Text] [Related]
8. Valrubicin-loaded immunoliposomes for specific vesicle-mediated cell death in the treatment of hematological cancers.
Georgievski A; Bellaye PS; Tournier B; Choubley H; Pais de Barros JP; Herbst M; Béduneau A; Callier P; Collin B; Végran F; Ballerini P; Garrido C; Quéré R
Cell Death Dis; 2024 May; 15(5):328. PubMed ID: 38734740
[TBL] [Abstract] [Full Text] [Related]
9. Time to full weight-bearing with the use of a calcium sulfate-calcium phosphate bone substitute as a bone void filler following extended curettage in the treatment of primary benign bone tumours.
Gyemi L; Selznick A; Petrisor B; Ghert M
J Orthop Surg (Hong Kong); 2024; 32(2):10225536241254200. PubMed ID: 38733211
[TBL] [Abstract] [Full Text] [Related]
10. Inhibition of Prostate cancer Cell Survival and Proliferation by Carnosic Acid Is Associated with Inhibition of Akt and Activation of AMPK Signaling.
Nadile M; Sze NSK; Fajardo VA; Tsiani E
Nutrients; 2024 Apr; 16(9):. PubMed ID: 38732504
[TBL] [Abstract] [Full Text] [Related]
11. The Efficacy of Three Different Oral Hygiene Regimens in Preventing Chemotherapy-Induced Oral Mucositis in Pediatric Patients Receiving Hematopoietic Stem Cell Transplantation.
Aygunes U; Karagun BS; Sasmaz I; Antmen B
Klin Padiatr; 2024 May; 236(3):180-188. PubMed ID: 38729129
[TBL] [Abstract] [Full Text] [Related]
12. Personalized Timing for Allogeneic Stem-Cell Transplantation in Hematologic Neoplasms: A Target Trial Emulation Approach Using Multistate Modeling and Microsimulation.
Gregorio C; Spreafico M; D'Amico S; Sauta E; Asti G; Lanino L; Tentori CA; Platzbecker U; Haferlach T; Diez-Campelo M; Fenaux P; Komrokji R; Della Porta MG; Ieva F
JCO Clin Cancer Inform; 2024 May; 8():e2300205. PubMed ID: 38723213
[TBL] [Abstract] [Full Text] [Related]
13. Diagnostic leukapheresis reveals distinct phenotypes of NSCLC circulating tumor cells.
Rieckmann LM; Spohn M; Ruff L; Agorku D; Becker L; Borchers A; Krause J; O'Reilly R; Hille J; Velthaus-Rusik JL; Beumer N; Günther A; Willnow L; Imbusch CD; Iglauer P; Simon R; Franzenburg S; Winter H; Thomas M; Bokemeyer C; Gagliani N; Krebs CF; Sprick M; Hardt O; Riethdorf S; Trumpp A; Stoecklein NH; Peine S; Rosenstiel P; Pantel K; Loges S; Janning M
Mol Cancer; 2024 May; 23(1):93. PubMed ID: 38720314
[TBL] [Abstract] [Full Text] [Related]
14. Incidence and survival of primary metastatic breast cancer in Denmark; implication of breast cancer screening, classification, and staging practice.
Berg T; Jensen MB; Rossing M; Axelsen CT; Kümler I; Søndergaard L; Vogsen M; Knoop AS; Ejlertsen B
Acta Oncol; 2024 May; 63():277-287. PubMed ID: 38711384
[TBL] [Abstract] [Full Text] [Related]
15. bone mineral density as an individual prognostic biomarker in NSCLC patients treated with immune checkpoint inhibitors.
Lou J; Gong B; Li Y; Guo Y; Li L; Wang J; Liu W; You Z; Zhang H; Pan F; Liang B; Yang L; Zhou G
Front Immunol; 2024; 15():1332303. PubMed ID: 38698843
[TBL] [Abstract] [Full Text] [Related]
16. Clinical outcomes of pomalidomide-based and daratumumab-based therapies in patients with relapsed/refractory multiple myeloma: A real-world cohort study in China.
Han X; Jiang X; He J; Zheng G; Xiong Y; Wen Y; Yang Y; He D; Chen Q; Zhao Y; Li Y; Wu W; Cai Z
Cancer Med; 2024 May; 13(9):e7232. PubMed ID: 38698679
[TBL] [Abstract] [Full Text] [Related]
17. Diagnosis, treatment, and surveillance of Diamond-Blackfan anaemia syndrome: international consensus statement.
Wlodarski MW; Vlachos A; Farrar JE; Da Costa LM; Kattamis A; Dianzani I; Belendez C; Unal S; Tamary H; Pasauliene R; Pospisilova D; de la Fuente J; Iskander D; Wolfe L; Liu JM; Shimamura A; Albrecht K; Lausen B; Bechensteen AG; Tedgard U; Puzik A; Quarello P; Ramenghi U; Bartels M; Hengartner H; Farah RA; Al Saleh M; Hamidieh AA; Yang W; Ito E; Kook H; Ovsyannikova G; Kager L; Gleizes PE; Dalle JH; Strahm B; Niemeyer CM; Lipton JM; Leblanc TM;
Lancet Haematol; 2024 May; 11(5):e368-e382. PubMed ID: 38697731
[TBL] [Abstract] [Full Text] [Related]
18. Optimizing radiotherapy strategies for skull base chordoma: a comprehensive meta-analysis and systematic review of treatment modalities and outcomes.
Palavani LB; Borges P; Andreão FF; Borges J; Batista S; Oliveira LB; Ferreira MY; Reis PCA; Pontes J; Negri H; Beer-Furlan A; Krishna C; Bertani R; Rassi MS
Neurosurg Focus; 2024 May; 56(5):E11. PubMed ID: 38691862
[TBL] [Abstract] [Full Text] [Related]
19. Supramarginal resection of skull base chordomas: proof of concept and preliminary outcomes.
Rychen J; Constanzo F; Xu Y; Johnstone TM; Bex A; Rinaldi M; Lee CK; Fernandez-Miranda JC
Neurosurg Focus; 2024 May; 56(5):E3. PubMed ID: 38691859
[TBL] [Abstract] [Full Text] [Related]
20. Early skeletal outcomes after hematopoietic stem and progenitor cell gene therapy for Hurler syndrome.
Consiglieri G; Tucci F; De Pellegrin M; Guerrini B; Cattoni A; Risca G; Scarparo S; Sarzana M; Pontesilli S; Mellone R; Gasperini S; Galimberti S; Silvani P; Filisetti C; Darin S; Forni G; Miglietta S; Santi L; Facchini M; Corti A; Fumagalli F; Cicalese MP; Calbi V; Migliavacca M; Barzaghi F; Ferrua F; Gallo V; Recupero S; Canarutto D; Doglio M; Tedesco L; Volpi N; Rovelli A; la Marca G; Valsecchi MG; Zancan S; Ciceri F; Naldini L; Baldoli C; Parini R; Gentner B; Aiuti A; Bernardo ME
Sci Transl Med; 2024 May; 16(745):eadi8214. PubMed ID: 38691622
[TBL] [Abstract] [Full Text] [Related]
[Next]
